Chemically Grafted Nanozyme Composite Cryogels to Enhance Antibacterial and Biocompatible Performance for Bioliquid Regulation and Adaptive Bacteria Trapping

Yanyan Li,Dingqian Wang,Jie Wen,Peng Yu,Jinming Liu,Jianshu Li,Hetao Chu
DOI: https://doi.org/10.1021/acsnano.1c06983
IF: 17.1
2021-01-01
ACS Nano
Abstract:Excessive biofluid and infection around wounds hinder wound healing. However, conventionally antibacterial wound dressings cannot simultaneously achieve effective biofluid control and intelligent infection treatment, tending to over-hydrate wounds and develop drug-resistant bacteria due to the limitations of antibacterial components and material structures. The design of a nanozyme composite cryogel with interconnected macroporous structures, excellent designability, and lower chance of drug-resistance is greatly needed. Herein, Fe-MIL-88NH(2) nanozyme is grafted to glycidyl methacrylate functionalized dialdehyde chitosan via Schiff base reaction, and acryloyl Pluronic 127 (PF127-DA) is used as a cross-linking agent to fabricate nanozyme composite cryogels (CSG-M-x) as a wound dressing to enhance antibacterial and biocompatible performance for biofluid management and wound infection therapy. CSG-M-x has great hydrophilicity, acid-enhanced positive charge, pH-responsive release, rebinding of nanozymes, and excellent peroxidase and oxidase mimicry activity (generation of center dot OH and O-2(center dot-) radicals). Notably, due to the negative potential of bacteria, the impact of infection on pH value, and the enzyme-like activity as well as the reversible release of nanozymes influenced by pH, CSG-M-x can achieve intelligently adaptive trapping and killing of bacteria. CSG-M-x has enormous potential to be a next-generation wound dressing for biofluid management and bacterial infection treatment in the clinic.
What problem does this paper attempt to address?